1 January 2017 in Arquivos Brasileiros de Oftalmologia
The aim of this study was to evaluate tear osmolarity, tear film function, and ocular surface changes in patients with psoriasis. At a single center, 30 eyes of 30 patients with psoriasis (group 1) and 30 eyes of 30 healthy individuals (group 2) were evaluated using the Ocular Surface Disease Index (OSDI) questionnaire, Schirmer I test, tear film break-up time (TBUT) test, scoring of ocular surface fluorescein staining using a modified Oxford scale, and tear osmolarity measurement. Tear osmolarity values, OSDI, and Oxford scale scores were significantly higher in group 1 (309.8 ± 9.4 mOsm, 38.9 ± 1.1, and 0.7 ± 1.1, respectively) than in group 2 (292.7 ± 7.7 mOsm, 4.2 ± 0.3, and 0.1 ± 0.3, respectively; p<0.01 for all). TBUT was significantly lower in group 1 (8.7 ± 3.6 s) than in group 2 (18.1 ± 2.8 s; p<0.001). No significant differences were detected in Schirmer I test values between the groups (16.2 ± 2.5 mm in group 1 and 16.6 ± 2.3 mm in group 2; p=0.629). The results of this study showed that psoriasis may influence tear osmolarity and tear film function. Patients with psoriasis showed tear hyperosmolarity and tear film dysfunction.
1 August 2018 in Journal of Ankara University Faculty of Medicine
21 December 2018 in TURKDERM
25 April 2019 in Journal of Cosmetic Dermatology
17 March 2018 in Dicle Tıp Dergisi
Objectives: Hidradenitis suppurativa is seen as a result of the occlusion, constriction and bacterial infection of the apocrine glands in bilateral axillas, submammarian areas, neck, inguinal regions, flexural surfaces of the thighs and anogenital areas. Among the biological agents adalimumab is a recombinant human IgG1 monoclonal antibody; TNF-α antagonist approved to be used in the treatment of hidradenitissuppurativa. Methods: In this study, 12 patients resistant to conventional treatments with moderate severity, Hurley stage 2 or 3 were started subcutaneous adalimumab treatment. The disease activities upon the hidradenitis suppurativa, clinical severity index and life quality index of the patients were examined both before and 1 year after the treatment. Results: Twelve patients were recruited. In the examination of the hidradenitis suppurativa clinical severity scores, significant clinical responses were noted in 9 (75%) patients. While the mean value of the life quality index was 14.4±6.9 before the treatment, it was determined to be significantly decreased to 4.3±3.8 after the treatment. Conclusion: We concluded that adalimumab; the unique biological agent approved to be used in the treatment of treatment-resistant, moderate-severe hidradenitis suppurativa is efficient and safe in similar ratios with the previous clinical studies in the literature.
7 September 2020 in American Journal of Surgical Case Reports
Pemphigus is an autoimmune and life-threatening disease. Esophageal involvement of pemphigus vulgaris is rare. The most common presenting symptoms are odynophagia and dysphagia. Here, I present one cases of pemphigus vulgaris presenting with dysphagia because of esophageal involvement of the disease. In case, a 27-year-old female patient with a prior diagnosis of pemphigus vulgaris presented with dysphagia. Esophagogastroduodenoscopy showed diffuse mucosal exfoliation and oozing bleeding of the esophagus. The patient recovered after the administration of corticosteroids, pantoprazole and azathioprurine.